* Vericel Corp VCEL.OQ VCEL.O is expected to show a rise in
quarterly revenue when it reports results on May 5.
* The Cambridge, Massachusetts-based company is expected to
report a 20.1% increase in revenue to $32.046 million from
$26.68 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Vericel Corp is for a
loss of 4 cents per share. For the same quarter last year, the
company reported a loss of 10 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Vericel Corp is
$60, about 4% below its last closing price of $62.42.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 0.20 0.20 0.25 Beat 23.5
Sep. 30 2020 -0.07 -0.06 0.08 Beat 223.9
Jun. 30 2020 -0.18 -0.21 -0.18 Beat 12.9
Mar. 31 2020 -0.08 -0.08 -0.10 Missed -22.4
Dec. 0.20 0.20 0.20 Met 1.7
31 2019
Sep. 30 2019 -0.04 -0.02 0.07 Beat 519.9
Jun. 30 2019 -0.46 -0.46 -0.05 Beat 89.2
Mar. 31 2019 -0.07 -0.07 -0.07 Met -2.9
This summary was machine generated May 3 at 12:58 GMT. All
figures in US dollars unless otherwise stated